Axsome Therapeutics (AXSM) Equity Ratio (2015 - 2026)
Axsome Therapeutics recorded quarterly Equity Ratio of 0.08 in Q1 2026, down 40.24% quarter-over-quarter from 0.13 in Q4 2025, and down 14.21% year-over-year from 0.09 in Q1 2025.
Axsome Therapeutics' Equity Ratio history runs 12 years deep, the most recent figure standing at 0.08 for Q1 2026.
- In Q1 2026, Equity Ratio fell 14.21% year-over-year to 0.08; the TTM figure through Mar 2026 stood at 0.08 (down 14.21% YoY), while the FY2025 annual figure was 0.13, up 27.63% from the prior year.
- Equity Ratio came in at 0.08 for Q1 2026 at Axsome Therapeutics, down from 0.13 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.46 in Q3 2022 to a low of 0.08 in Q1 2026.
- A 5-year average of 0.22 and a median of 0.17 in 2022 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio slumped 83.12% in 2022 and jumped 441.51% in 2023, its largest moves.
- Axsome Therapeutics' Equity Ratio stood at 0.33 in 2022, then slipped by 1.77% to 0.32 in 2023, then slumped by 69.11% to 0.1 in 2024, then gained by 27.63% to 0.13 in 2025, then tumbled by 40.24% to 0.08 in 2026.
- According to Business Quant data, Equity Ratio over the past three periods registered 0.08, 0.13, and 0.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.10 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.26 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.37 |
| Jun 30, 2021 | 0.50 |
| Mar 31, 2021 | 0.58 |
| Dec 31, 2020 | 0.61 |
| Sep 30, 2020 | 0.66 |
| Jun 30, 2020 | 0.81 |
| Mar 31, 2020 | 0.79 |
| Dec 31, 2019 | 0.81 |
| Sep 30, 2019 | 0.15 |
| Jun 30, 2019 | 0.44 |
| Mar 31, 2019 | 0.40 |
| Dec 31, 2018 | 0.06 |
| Sep 30, 2018 | 0.05 |
| Jun 30, 2018 | 0.32 |
| Mar 31, 2018 | 0.45 |
| Dec 31, 2017 | 0.47 |
| Sep 30, 2017 | 0.52 |
| Jun 30, 2017 | 0.58 |
| Mar 31, 2017 | 0.63 |
| Dec 31, 2016 | 0.56 |
| Sep 30, 2016 | 0.81 |
| Jun 30, 2016 | 0.87 |
| Mar 31, 2016 | 0.91 |
| Dec 31, 2015 | 0.95 |